16 publications
| Name | Date | Type | Actions |
|---|---|---|---|
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
29/04/2024 | Public releases | |
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
24/04/2024 | Public releases | |
Buyback programs - March 2024 Monthly communication regarding buyback programs |
04/04/2024 | Description of buyback programs | |
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
20/03/2024 | Public releases | |
Buyback programs – January 2024 Monthly communication regarding buyback programs |
02/02/2024 | Description of buyback programs | |
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
24/01/2024 | Public releases | |
Third quarter revenues: €132 million |
14/10/2021 | Public releases | |
2021 first half results 2021 Half year results |
29/07/2021 | Public releases | |
Descriptif du programme de rachat d’actions propres soumis à l’assemblée générale mixte du 27 mai 2021 (french) Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions autorisé par l’assemblée générale mixte du 27 mai 2021. |
28/05/2021 | Description of buyback programs | |
Availability of the 2020 universal registration document Vetoquinol informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021. |
28/04/2021 | Public releases |